BOSTON, Feb. 3, 2026 /PRNewswire/ -- ZipBio, a biotechnology company pioneering AI-driven protein therapeutics, announced an exclusive license agreement with MeiraGTx Holdings plc (Nasdaq: MGTX), a ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...

A three-year-old laser technology startup is placing a $1.3 billion bet on uranium enrichment in Oak Ridge. Laser Isotope Separation Technologies plans to build an enrichment complex on Duct Island — ...

Laser therapy reduces bleeding and post-operative pain compared to osseous surgery by cauterizing nerve endings and blood vessels. The procedure targets diseased tissue specifically, leaving healthy ...

Eli Lilly has returned to Nimbus Therapeutics for another metabolic collaboration, this time focused on the red-hot R&D space of oral obesity therapies. The latest partnership will see Lilly pass ...

Trump’s battleship plan clashes with decades of U.S. naval strategy and technology shifts Experts described it as a "prestige project," a "bomb magnet" and said that "this ship will never sail." Even ...

Add Yahoo as a preferred source to see more of our stories on Google. The battleships will be made from steel and armed with missiles, guns, hypersonic weapons and lasers - AFP The US will commission ...

President Donald Trump announced new "Trump-class" ships for the US Navy Golden Fleet. Trump said that up to 25 ships will be built, with construction set to start immediately. The Navy said these ...

(RTTNews) - Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (INVA), announced that the U.S. Food and Drug Administration approved NUZOLVENCE (zoliflodacin) for oral suspension, a first ...

Eli Lilly (LLY) shares spiked ~3% on Thursday after the obesity drugmaker posted Phase 3 data showing its next-gen therapy retatrutide can generate up to 24% of weight loss, a “best-in-class" efficacy ...